{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T05:05:25Z","timestamp":1733202325410,"version":"3.30.0"},"reference-count":59,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2024.14776","type":"journal-article","created":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T11:12:04Z","timestamp":1729854724000},"source":"Crossref","is-referenced-by-count":0,"title":["Biomarker potential of nuclear Nrf2 activation in the ABC subtype of diffuse large B\u2011cell lymphoma"],"prefix":"10.3892","volume":"29","author":[{"given":"Chin-Mu","family":"Hsu","sequence":"first","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807377, Taiwan, R.O.C."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Yu","family":"Kao","sequence":"additional","affiliation":[{"name":"Cancer Center, Kaohsiung Medical University Hospital, Kaohsiung 807377, Taiwan, R.O.C."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Hung","family":"Yen","sequence":"additional","affiliation":[{"name":"Center for Cancer Research, Kaohsiung Medical University, Kaohsiung 807378, Taiwan, R.O.C."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-En","family":"Hsiao","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cell Biology, University of California, Berkeley, CA 94720, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Feng","family":"Cho","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807377, Taiwan, R.O.C."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Ching","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807377, Taiwan, R.O.C."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsung-Jang","family":"Yeh","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807377, Taiwan, R.O.C."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeng-Shiun","family":"Du","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807377, Taiwan, R.O.C."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-Hong","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807377, Taiwan, R.O.C."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzu-Yu","family":"Hsieh","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807377, Taiwan, R.O.C."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Hsiao","sequence":"additional","affiliation":[{"name":"Center for Computational and Integrative Biology, University of Rutgers\u2011Camden, Camden, NJ\u00a008102, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhsin","family":"Tsai","sequence":"additional","affiliation":[{"name":"Graduate Institute of Chinese Medicine, School of Chinese Medicine, China Medical University, Taichung 404328, Taiwan, R.O.C."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Chuan","family":"Hung","sequence":"additional","affiliation":[{"name":"Department of Long\u2011Term Care and Health Management, Cheng Shiu University, Kaohsiung 833301, Taiwan, R.O.C."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Chang","family":"Liu","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807377, Taiwan, R.O.C."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kung-Chao","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 701401, Taiwan, R.O.C."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Hua","family":"Hsiao","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807377, Taiwan, R.O.C."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2024,10,25]]},"reference":[{"key":"key20241202101854_b1-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1038\/s41467-024-47198-4","article-title":"Combination of acalabrutinib with lenalidomide and rituximab in relapsed\/refractory aggressive B-cell non-Hodgkin lymphoma: A single-arm phase II trial","volume":"15","author":"Park","year":"2024","journal-title":"Nat Commun"},{"key":"key20241202101854_b2-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/ajh.25460","article-title":"Diffuse large B-cell lymphoma: 2019 update on diagnosis, risk stratification, and treatment","volume":"94","author":"Liu","year":"2019","journal-title":"Am J Hematol"},{"key":"key20241202101854_b3-ol-29-1-14776","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(23)02705-8","article-title":"B-cell non-Hodgkin lymphomas","author":"Silkenstedt","year":"2024"},{"key":"key20241202101854_b4-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1056\/NEJMra2027612","article-title":"Diffuse Large B-Cell Lymphoma","volume":"384","author":"Sehn","year":"2021","journal-title":"N Engl J Med"},{"key":"key20241202101854_b5-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"key20241202101854_b6-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1182\/bloodadvances.2023011517","article-title":"Sinonasal DLBCL: Molecular profiling identifies subtypes with distinctive prognosis and targetable genetic features","volume":"8","author":"Eriksen","year":"2024","journal-title":"Blood Adv"},{"key":"key20241202101854_b7-ol-29-1-14776","first-page":"1922","article-title":"BCL10 mutations define distinct dependencies guiding precision therapy for DLBCL","volume":"12","author":"Xia","year":"2022","journal-title":"Cancer Discov"},{"key":"key20241202101854_b8-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1200\/JCO.2014.55.5714","article-title":"Lenalidomide combined with R-CHOP overcomes negative prognostic impact of Non-germinal center B-cell phenotype in newly diagnosed diffuse Large B-Cell lymphoma: A phase II study","volume":"33","author":"Nowakowski","year":"2015","journal-title":"J Clin Oncol"},{"key":"key20241202101854_b9-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1038\/s41375-020-0743-y","article-title":"Single-agent activity of phosphatidylinositol 3-kinase inhibition with copanlisib in patients with molecularly defined relapsed or refractory diffuse large B-cell lymphoma","volume":"34","author":"Lenz","year":"2020","journal-title":"Leukemia"},{"key":"key20241202101854_b10-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1038\/nm.3884","article-title":"Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma","volume":"21","author":"Wilson","year":"2015","journal-title":"Nat Med"},{"key":"key20241202101854_b11-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1182\/blood.V120.21.686.686","article-title":"The Bruton's tyrosine kinase (BTK) inhibitor, ibrutinib (PCI-32765), has preferential activity in the ABC subtype of relapsed\/refractory de novo diffuse large B-cell lymphoma (DLBCL): Interim results of a multicenter, open-label, phase 2 study","volume":"120","author":"Wilson","year":"2012","journal-title":"Blood"},{"key":"key20241202101854_b12-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1182\/blood.2018891598","article-title":"Ibrutinib plus lenalidomide and rituximab has promising activity in relapsed\/refractory non-germinal center B-cell-like DLBCL","volume":"134","author":"Goy","year":"2019","journal-title":"Blood"},{"key":"key20241202101854_b13-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"4127","DOI":"10.1158\/1078-0432.CCR-16-2818","article-title":"A Phase 2\/3 multicenter, randomized, open-label study to compare the efficacy and safety of lenalidomide versus Investigator's choice in patients with relapsed or refractory diffuse large B-Cell lymphoma","volume":"23","author":"Czuczman","year":"2017","journal-title":"Clin Cancer Res"},{"key":"key20241202101854_b14-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1111\/cas.13537","article-title":"NRF2 addiction in cancer cells","volume":"109","author":"Kitamura","year":"2018","journal-title":"Cancer Sci"},{"key":"key20241202101854_b15-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"116324","DOI":"10.1016\/j.biopha.2024.116324","article-title":"Targeting Nrf2 to treat thyroid cancer","volume":"173","author":"Gong","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"key20241202101854_b16-ol-29-1-14776","first-page":"375","article-title":"Importance of the Keap1-Nrf2 pathway in NSCLC: Is It a possible biomarker?","volume":"9","author":"Barrera-Rodriguez","year":"2018","journal-title":"Biomed Rep"},{"key":"key20241202101854_b17-ol-29-1-14776","first-page":"1918","article-title":"NRF2 is overexpressed in ovarian epithelial carcinoma and is regulated by gonadotrophin and sex-steroid hormones","volume":"27","author":"Liao","year":"2012","journal-title":"Oncol Rep"},{"key":"key20241202101854_b18-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3390\/antiox13010070","article-title":"The Multifaceted Roles of NRF2 in Cancer: Friend or Foe?","volume":"13","author":"Glorieux","year":"2024","journal-title":"Antioxidants (Basel)"},{"key":"key20241202101854_b19-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.freeradbiomed.2018.04.009","article-title":"Nrf2 signaling and autophagy are complementary in protecting breast cancer cells during glucose deprivation","volume":"120","author":"Walker","year":"2018","journal-title":"Free Radic Biol Med"},{"key":"key20241202101854_b20-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1080\/15384101.2017.1312224","article-title":"Nrf2 promotes progression of non-small cell lung cancer through activating autophagy","volume":"16","author":"Wang","year":"2017","journal-title":"Cell Cycle"},{"key":"key20241202101854_b21-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.freeradbiomed.2015.06.014","article-title":"p62 links autophagy and Nrf2 signaling","volume":"88","author":"Jiang","year":"2015","journal-title":"Free Radic Biol Med"},{"key":"key20241202101854_b22-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.trsl.2017.11.007","article-title":"Nrf2-p62 autophagy pathway and its response to oxidative stress in hepatocellular carcinoma","volume":"193","author":"Bartolini","year":"2018","journal-title":"Transl Res"},{"key":"key20241202101854_b23-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: An enhanced web server for Large-scale expression profiling and interactive analysis","volume":"47","author":"Tang","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"key20241202101854_b24-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","article-title":"UALCAN: An update to the integrated cancer data analysis platform","volume":"25","author":"Chandrashekar","year":"2022","journal-title":"Neoplasia"},{"key":"key20241202101854_b25-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"key20241202101854_b26-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"4150","DOI":"10.3390\/cancers15164150","article-title":"High G9a expression in DLBCL and its inhibition by niclosamide to induce autophagy as a therapeutic approach","volume":"15","author":"Hsu","year":"2023","journal-title":"Cancers (Basel)"},{"key":"key20241202101854_b27-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3892\/ijo.2013.1942","article-title":"Bufalin induces G2\/M phase arrest and triggers autophagy via the TNF, JNK, BECN-1 and ATG8 pathway in human hepatoma cells","volume":"43","author":"Hsu","year":"2013","journal-title":"Int J Oncol"},{"key":"key20241202101854_b28-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20241202101854_b29-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3322\/canjclin.55.6.368","article-title":"Staging non-Hodgkin lymphoma","volume":"55","author":"Armitage","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"key20241202101854_b30-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ccell.2018.03.022","article-title":"NRF2 and the hallmarks of cancer","volume":"34","author":"Rojo de la Vega","year":"2018","journal-title":"Cancer Cell"},{"key":"key20241202101854_b31-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/ncb2021","article-title":"The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1","volume":"12","author":"Komatsu","year":"2010","journal-title":"Nat Cell Biol"},{"key":"key20241202101854_b32-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3892\/mmr.2021.12067","article-title":"Upregulation of antioxidant and autophagy pathways via NRF2 activation protects spinal cord neurons from ozone damage","volume":"23","author":"Zhang","year":"2021","journal-title":"Mol Med Rep"},{"key":"key20241202101854_b33-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1159\/000503095","article-title":"Performance status assessment by using ECOG (Eastern Cooperative Oncology Group) score for cancer patients by oncology healthcare professionals","volume":"12","author":"Azam","year":"2019","journal-title":"Case Rep Oncol"},{"key":"key20241202101854_b34-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1053\/j.seminhematol.2023.11.004","article-title":"Epidemiology and etiology of diffuse large B-cell lymphoma","volume":"60","author":"Wang","year":"2023","journal-title":"Semin Hematol"},{"key":"key20241202101854_b35-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"key20241202101854_b36-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.3324\/haematol.2019.220475","article-title":"Variable global distribution of cell-of-origin from the ROBUST phase III study in diffuse large B-cell lymphoma","volume":"105","author":"Nowakowski","year":"2020","journal-title":"Haematologica"},{"key":"key20241202101854_b37-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/j.leukres.2007.03.017","article-title":"The GCB subtype of diffuse large B-cell lymphoma is less frequent in Asian countries","volume":"31","author":"Shiozawa","year":"2007","journal-title":"Leuk Res"},{"key":"key20241202101854_b38-ol-29-1-14776","doi-asserted-by":"publisher","DOI":"10.3390\/cells10030675","article-title":"Predictive and prognostic molecular factors in diffuse large B-Cell Lymphomas.","volume":"10","author":"Pileri","year":"2021","journal-title":"Cells"},{"key":"key20241202101854_b39-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1093\/carcin\/bgn095","article-title":"Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2","volume":"29","author":"Wang","year":"2008","journal-title":"Carcinogenesis"},{"key":"key20241202101854_b40-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.3390\/ijms19113503","article-title":"NRF2 is one of the players involved in bone marrow mediated drug resistance in multiple myeloma","volume":"19","author":"Yen","year":"2018","journal-title":"Int J Mol Sci"},{"key":"key20241202101854_b41-ol-29-1-14776","first-page":"573","article-title":"Expression of Keap1 and Nrf2 in diffuse large B-cell lymphoma and its clinical significance","volume":"16","author":"Yi","year":"2018","journal-title":"Exp Ther Med"},{"key":"key20241202101854_b42-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"41074","DOI":"10.1074\/jbc.M110.145862","article-title":"Hepatitis B virus induces expression of antioxidant response element-regulated genes by activation of Nrf2","volume":"285","author":"Schaedler","year":"2010","journal-title":"J Biol Chem"},{"key":"key20241202101854_b43-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.cbi.2007.03.006","article-title":"HBx or HCV core gene expression in HepG2 human liver cells results in a survival benefit against oxidative stress with possible implications for HCC development","volume":"168","author":"Severi","year":"2007","journal-title":"Chem Biol Interact"},{"key":"key20241202101854_b44-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1111\/liv.16048","article-title":"Impaired HBsAg release and antiproliferative\/antioxidant cell regulation by HBeAg-negative patient isolates reflects an evolutionary process","volume":"44","author":"Basic","year":"2024","journal-title":"Liver Int"},{"key":"key20241202101854_b45-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.jhep.2014.11.028","article-title":"Intracellular accumulation of subviral HBsAg particles and diminished Nrf2 activation in HBV genotype G expressing cells lead to an increased ROI level","volume":"62","author":"Peiffer","year":"2015","journal-title":"J Hepatol"},{"key":"key20241202101854_b46-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s12964-023-01351-6","article-title":"A state-of-the-art review on the NRF2 in Hepatitis virus-associated liver cancer","volume":"21","author":"Kalantari","year":"2023","journal-title":"Cell Commun Signal"},{"key":"key20241202101854_b47-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"e0128723","DOI":"10.1128\/jvi.01287-23","article-title":"Oxidative stress sensor Keap1 recognizes HBx protein to activate the Nrf2\/ARE signaling pathway, thereby inhibiting hepatitis B virus replication","volume":"97","author":"Ariffianto","year":"2023","journal-title":"J Virol"},{"key":"key20241202101854_b48-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"4659","DOI":"10.3390\/ijms20184659","article-title":"Effect of hepatitis viruses on the Nrf2\/Keap1-signaling pathway and its impact on viral replication and pathogenesis","volume":"20","author":"Bender","year":"2019","journal-title":"Int J Mol Sci"},{"key":"key20241202101854_b49-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1128\/MCB.00225-13","article-title":"The Keap1-Nrf2 system prevents onset of diabetes mellitus","volume":"33","author":"Uruno","year":"2013","journal-title":"Mol Cell Biol"},{"key":"key20241202101854_b50-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ejphar.2009.08.022","article-title":"Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolide","volume":"620","author":"Shin","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"key20241202101854_b51-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.tem.2020.11.002","article-title":"Nrf2: The master and captain of beta cell fate","volume":"32","author":"Baumel-Alterzon","year":"2021","journal-title":"Trends Endocrinol Metab"},{"key":"key20241202101854_b52-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"4826724","DOI":"10.1155\/2017\/4826724","article-title":"The Nrf2\/Keap1\/ARE pathway and oxidative stress as a therapeutic target in type II diabetes mellitus","volume":"2017","author":"David","year":"2017","journal-title":"J Diabetes Res"},{"key":"key20241202101854_b53-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"e00099","DOI":"10.1128\/MCB.00099-20","article-title":"The molecular mechanisms regulating the KEAP1-NRF2 Pathway","volume":"40","author":"Baird","year":"2020","journal-title":"Mol Cell Biol"},{"key":"key20241202101854_b54-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1182\/blood-2016-03-705814","article-title":"An oxidative stress-based mechanism of doxorubicin cytotoxicity suggests new therapeutic strategies in ABC-DLBCL","volume":"128","author":"Mai","year":"2016","journal-title":"Blood"},{"key":"key20241202101854_b55-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"113295","DOI":"10.1016\/j.celrep.2023.113295","article-title":"KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistance","volume":"42","author":"Zavitsanou","year":"2023","journal-title":"Cell Rep"},{"key":"key20241202101854_b56-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"13568","DOI":"10.1073\/pnas.0806268105","article-title":"Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy","volume":"105","author":"Shibata","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20241202101854_b57-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41375-024-02147-4","article-title":"Analysis of autophagy in DLBCL reveals subtype-specific differences and the preferential targeting of ULK1 inhibition in GCB-DLBCL provides a rationale as a new therapeutic approach","volume":"38","author":"Mandhair","year":"2024","journal-title":"Leukemia"},{"key":"key20241202101854_b58-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"856","DOI":"10.15252\/embj.201490784","article-title":"Autophagy in malignant transformation and cancer progression","volume":"34","author":"Galluzzi","year":"2015","journal-title":"EMBO J"},{"key":"key20241202101854_b59-ol-29-1-14776","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3390\/antiox13010127","article-title":"Using redox proteomics to gain new insights into neurodegenerative disease and protein modification","volume":"13","author":"Cadenas-Garrido","year":"2024","journal-title":"Antioxidants (Basel)"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T08:19:06Z","timestamp":1733127546000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2024.14776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,25]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,10,25]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2024.14776","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"type":"print","value":"1792-1074"},{"type":"electronic","value":"1792-1082"}],"subject":[],"published":{"date-parts":[[2024,10,25]]},"article-number":"30"}}